Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The company is headquartered in Hingham, Massachusetts and currently employs 21 full-time employees. The company has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. The company specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. The company eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
Mr. Harel Gadot is the Chairman of the Board of Microbot Medical Inc, joining the firm since 2016.
What is the price performance of MBOT stock?
The current price of MBOT is $2.35, it has decreased 9.26% in the last trading day.
What are the primary business themes or industries for Microbot Medical Inc?
Microbot Medical Inc belongs to Health Care industry and the sector is Health Care
What is Microbot Medical Inc market cap?
Microbot Medical Inc's current market cap is $157.8M
Is Microbot Medical Inc a buy, sell, or hold?
According to wall street analysts, 5 analysts have made analyst ratings for Microbot Medical Inc, including 2 strong buy, 4 buy, 1 hold, 0 sell, and 2 strong sell